Neok Bio
PrivateLast Round
Series A
Extension
Mar 30, 2026
Est. Valuation
$116.5M
Total Funding Raised
$100M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neok Bio operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Series A Extension round in March 2026.
Neok Bio is a biotechnology company that develops novel bispecific antibody drug conjugates (ADCs) for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neok Bio Comparables
Compare Neok Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sidewinder | 87% | |
| Genmab A/S | 83% | |
| Promatix Biosciences | 81% |
For institutional investors. Book with your work email.
Neok Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 30, 2026 | ||||
| Series A | Nov 4, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors grew 904% MoM, reaching 4.1K.
- Mar 30, 2026
$25M round led by ABL Bio, Inc.
For institutional investors. Book with your work email.
Neok Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neok Bio's valuation, stock price, and market status.
Is Neok Bio a public or private company?
Neok Bio is a private company.
What is the current stock price of Neok Bio?
Neok Bio is a private company, so its shares have no public market price. Caplight tracks Neok Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neok Bio worth (valuation)?
Neok Bio's valuation is estimated at $116.5M based on funding round data.
Can I buy Neok Bio stock?
Neok Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neok Bio's last funding round?
Neok Bio's most recent funding round was Series A Extension on March 30, 2026.
Who are the main investors in Neok Bio?
Investor information for Neok Bio is not publicly disclosed.
Will Neok Bio IPO soon?
No public IPO plans have been announced for Neok Bio.
How can I track Neok Bio secondary market activity?
Caplight tracks bids, offers, and trades in Neok Bio's shares on secondary markets.